inmune-bio
Delivered
Earnings Eye detected this earnings release on Friday, March 21, 2025 at 2:30:33 AM EDT and has distributed notifications to the Telegram channels listed at the bottom of the page.
Data sources leveraged on this page come from:
TradingViewCompany Information
- Ticker Symbol
- INMB
- Stock Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
Stock Trading Snapshot
- Market Cap
- $216.5M
- Current Price
- $8.1400
- Previous Close
- $8.3100
- Price Change
- -2.0457%
- Average Volume
- 379.3K
- Volume Amount
- $254.6K
Financial Metrics
Earnings Per Share
- Estimate
- $-0.547850
- Actual
- $-0.568550
- Surprise
- $-0.020700
- Surprise %
- -3.7784%
Revenue
- Estimate
- $0
- Actual
- $0
- Surprise
- $N/A
- Surprise %
- %
Notification Distribution
List of notifications sent to Telegram channels
Earnings releasedSent
3/21/25, 2:31 AM
INMB EPS Surprise:-3.78% Revenue Surprise: N/A EPS chain: $-9.75M / $-12.09M / $-0.57(Est: $-0.51) Revenue chain: N/A / N/A / N/A(N/A) MA50/MA200: 8.10 / 6.85 52WeekRange: 4.32~12.72 Close Price: 8.3100 Current Price: 8.1400 / -2.05%% Market Cap: $216.45M Sector: Healthcare - Biotechnology Release_date: 2025-03-21 06:30:33.359994+00:00 More details >>
Terminology
| Term | Definition |
|---|---|
| Ticker Symbol | A unique series of letters representing a publicly traded security. |
| Stock Exchange | The marketplace where securities are traded. |
| Sector | A category of the economy in which the company operates. |
| Industry | A specific category within a sector. |
| Market Cap | The total market value of a company's outstanding shares. |
| Current Price | The latest trading price of the stock. |
| Previous Close | The stock's closing price on the previous trading day. |
| Price Change | The percentage change in the stock's price from the previous close. |
| Average Volume | The average number of shares traded over a specific period. |
| Volume Amount | The total monetary value of shares traded. |
| Earnings Per Share | The portion of a company's profit allocated to each outstanding share. |
| Revenue | The total income generated by the company. |
| Estimate | The predicted value by analysts. |
| Actual | The reported value by the company. |
| Surprise | The difference between actual and estimated values. |
| Surprise % | The percentage difference between actual and estimated values. |